Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis

NCT04301752•Mansoura University Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Brucellosis

Interventions

MoCA

Locations

Egypt

Locations (1)

Mansoura University Hospital

Al Mansurah, Egypt

Key Dates

Start Date

February 1, 2019

Primary Completion Date

January 1, 2020

Completion Date

March 1, 2020

Last Updated

March 18, 2020

Related Studies

COMPLETED

Brucella Serology and History of Brucellosis in Patients With Modic Changes Type 1

NCT04911283

BrucellosisSpinal Degeneration

View study

Sponsors

Lead Sponsor

Mansoura University Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 18, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions